Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 453

1.
2.
3.

Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function.

Bader FM, Rogers RK, Kfoury AG, Gilbert EM, Horne BD, Stehlik J, Renlund DG.

Congest Heart Fail. 2009 Mar-Apr;15(2):63-7. doi: 10.1111/j.1751-7133.2009.00055.x.

4.

N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.

Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R.

N Engl J Med. 2005 Feb 17;352(7):666-75.

5.

[BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].

Valle R, Aspromonte N, Carbonieri E, De Michele G, Di Tano G, Giovinazzo P, Cioè R, Di Giacomo T, Milani L, Noventa F, Chiatto M.

Monaldi Arch Chest Dis. 2007 Sep;68(3):154-64. Italian.

PMID:
18361212
6.

B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.

Price JF, Thomas AK, Grenier M, Eidem BW, O'Brian Smith E, Denfield SW, Towbin JA, Dreyer WJ.

Circulation. 2006 Sep 5;114(10):1063-9. Epub 2006 Aug 28.

7.

Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.

Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, Lee SR, Kim KH, Park HW, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Kang JC.

Am J Cardiol. 2007 Apr 15;99(8):1051-4. Epub 2007 Mar 6.

PMID:
17437726
8.

Value of brain natriuretic peptide after acute myocardial infarction.

Güneş Y, Okçün B, Kavlak E, Erbaş C, Karcier S.

Anadolu Kardiyol Derg. 2008 Jun;8(3):182-7.

9.

B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.

Valle R, Aspromonte N, Feola M, Milli M, Canali C, Giovinazzo P, Carbonieri E, Ceci V, Cerisano S, Barro S, Milani L.

J Card Fail. 2005 Sep;11(7):498-503.

PMID:
16198244
10.

N-terminal pro-B-type natriuretic peptide predicts total and cardiovascular mortality in individuals with or without stable coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health Study.

März W, Tiran B, Seelhorst U, Wellnitz B, Bauersachs J, Winkelmann BR, Boehm BO; LURIC Study Team.

Clin Chem. 2007 Jun;53(6):1075-83. Epub 2007 Apr 19.

11.
12.

Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.

Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.

Am J Cardiol. 2008 Sep 15;102(6):733-7. doi: 10.1016/j.amjcard.2008.04.048. Epub 2008 Jul 9.

PMID:
18773998
13.

B-type natriuretic peptide levels in obese patients with advanced heart failure.

Horwich TB, Hamilton MA, Fonarow GC.

J Am Coll Cardiol. 2006 Jan 3;47(1):85-90. Epub 2005 Dec 15.

14.

Prognostic value of B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure.

Rogers RK, May HT, Anderson JL, Muhlestein JB.

Am Heart J. 2009 Nov;158(5):777-83. doi: 10.1016/j.ahj.2009.09.002.

PMID:
19853697
15.

Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery.

Nessmith MG, Fukuta H, Brucks S, Little WC.

Am J Cardiol. 2005 Nov 15;96(10):1445-8. Epub 2005 Oct 3.

PMID:
16275196
16.

Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.

Ang DS, Kong CF, Kao MP, Struthers AD.

Am Heart J. 2009 Jul;158(1):133-40. doi: 10.1016/j.ahj.2009.04.024.

PMID:
19540403
17.

Noninvasive assessment of left ventricular filling pressure after acute myocardial infarction: a prospective study of the relative prognostic utility of clinical assessment, echocardiography, and B-type natriuretic peptide.

Kruszewski K, Scott AE, Barclay JL, Small GR, Croal BL, Møller JE, Oh JK, Hillis GS.

Am Heart J. 2010 Jan;159(1):47-54. doi: 10.1016/j.ahj.2009.10.032.

PMID:
20102866
18.

Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.

Omland T, Sabatine MS, Jablonski KA, Rice MM, Hsia J, Wergeland R, Landaas S, Rouleau JL, Domanski MJ, Hall C, Pfeffer MA, Braunwald E; PEACE Investigators.

J Am Coll Cardiol. 2007 Jul 17;50(3):205-14. Epub 2007 Jun 29.

19.

B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.

Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, Frampton C, Turner J, Crozier IG, Yandle TG.

Circulation. 2003 Jun 10;107(22):2786-92. Epub 2003 May 27.

20.

B-type natriuretic peptide and extent of lesion on coronary angiography in stable coronary artery disease.

Sahinarslan A, Cengel A, Okyay K, Yazici HU, Elbey S, Cemri M, Ozdemir M, Timurkaynak T.

Coron Artery Dis. 2005 Jun;16(4):225-9.

PMID:
15915074
Items per page

Supplemental Content

Write to the Help Desk